CDK9-IN-39
CDK9-IN-39 (1-7a-B1) is an orally active inhibitor of cyclin-dependent kinase 9 (CDK9), with an IC50 value of 6.51 nM. By inhibiting the phosphorylation of RNA polymerase II at the Ser2 site, CDK9-IN-39 induces cell (apoptosis) and can be used for colorectal cancer research.
Product Specifications
Field of Research
Cell Biology, Epigenetics & Chromatin
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV808080 1.0 µg DNA
Dcaf8 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details 
LS007138 100 µg
Troponin T1 (TNNT1) (NM_003283) Human Over-expression Lysate
Sign In for Pricing
View Details 
DLR-PPP2R4-Ra-96T 96 Tests
Rat Protein Phosphatase 2A Activator, Regulatory Subunit 4 (PPP2R4) ELISA Kit
Sign In for Pricing
View Details